Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Aug 15, 2024; 16(8): 3559-3584
Published online Aug 15, 2024. doi: 10.4251/wjgo.v16.i8.3559
Published online Aug 15, 2024. doi: 10.4251/wjgo.v16.i8.3559
Table 3 Relationship between the HMGA2 and clinicopathologic characteristics
Patient-related factors | HMGA2 | χ2 | P value | |
Low (n = 22) | High (n = 22) | |||
Gender | 0.109 | 0.741 | ||
Male | 16 | 15 | ||
Female | 6 | 7 | ||
Age (years) | 1.467 | 0.226 | ||
< 60 | 10 | 14 | ||
≥ 60 | 12 | 8 | ||
Tumor sizes | 0.910 | 0.340 | ||
< 5 cm | 16 | 13 | ||
≥ 5 cm | 6 | 9 | ||
Differentiation grade | 3.536 | 0.060 | ||
Poor | 11 | 17 | ||
Well | 11 | 5 | ||
N stage | 9.821 | 0.002 | ||
N0 | 13 | 3 | ||
N1-N3 | 9 | 19 | ||
T stage | 4.956 | 0.026 | ||
T1-T2 | 11 | 4 | ||
T3-T4 | 11 | 18 |
- Citation: Zhang LX, Luo PQ, Wei ZJ, Xu AM, Guo T. Expression and significant roles of the long non-coding RNA CASC19/miR-491-5p/HMGA2 axis in the development of gastric cancer. World J Gastrointest Oncol 2024; 16(8): 3559-3584
- URL: https://www.wjgnet.com/1948-5204/full/v16/i8/3559.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i8.3559